0001104659-21-046654.txt : 20210405
0001104659-21-046654.hdr.sgml : 20210405
20210405171430
ACCESSION NUMBER: 0001104659-21-046654
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210401
FILED AS OF DATE: 20210405
DATE AS OF CHANGE: 20210405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White William Richard
CENTRAL INDEX KEY: 0001778739
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 21806509
MAIL ADDRESS:
STREET 1: C/O AKERO THERAPEUTICS, INC.
STREET 2: 170 HARBOR WAY 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
tm2112039-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-04-01
0
0001744659
Akero Therapeutics, Inc.
AKRO
0001778739
White William Richard
C/O AKERO THERAPEUTICS, INC.
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
Common Stock
2021-04-01
4
M
0
50000
7.01
A
52270
D
Common Stock
2021-04-01
4
S
0
48851
28.6281
D
3419
D
Common Stock
2021-04-01
4
S
0
1149
29.2908
D
2270
D
Stock Option (Right to Buy)
7.01
2021-04-01
4
M
0
50000
0
D
2029-04-04
Common Stock
50000
364029
D
Shares sold pursuant to a Rule 10b5-1 trading plan dated October 5, 2020, as amended on November 18, 2020 previously adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $28.25 to $29.18, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $29.25 to $29.35, inclusive.
25% of this option vested on April 1, 2020, and the remaining 75% of this option shall vest in 36 equal monthly installments thereafter.
/s/ Jonathan Young, Attorney-in-fact
2021-04-05